NCT00344851View on ClinicalTrials.gov

Exenatide and Metformin Therapy in Overweight Women With PCOS

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

June 30, 2007

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

metformin, exenatide or combined (metformin & exenatide )

Trial Locations (1)

70808

Facility: Metabolic Center of Louisiana Research Foundation, Baton Rouge

Sponsors
All Listed Sponsors
collaborator

Amylin Pharmaceuticals, LLC.

INDUSTRY

lead

Metabolic Center of Louisiana Research Foundation

OTHER